Bio
Raagini Jawa is a clinician-investigator at the Center for Research on Health Care at the University of Pittsburgh School of Medicine. She earned her MD-MPH from Boston University and is triple board-certified in internal medicine, infectious diseases, and addiction medicine. Her clinical work focuses on HIV, endovascular infections, xylazine-associated wound care, and addiction treatment, all of which directly inform her research program.
Dr. Jawa’s scholarship is centered on reducing health disparities and preventing both infectious and non-infectious harms among people who use unregulated substances. She leads the Harm Reduction Research Collaborative, a multidisciplinary lab dedicated to integrating harm reduction approaches into healthcare settings, promoting evidence-based drug policy reform, and advancing patient-centered care.
She received a NIDA K12 award to evaluate harm reduction service implementation across Pennsylvania Centers of Excellence. Her current work is supported by a NIDA K23 HEAL Initiative Career Development Award in Implementation Science. This research includes a Hybrid Type 3 trial, “Prescribe to Prevent HIV,” which aims to equip outpatient addiction clinics to support safer drug use and prevent HIV and other serious infections.